Metronidazole is a limited spectrum antibiotic that actively deters the growth of protozoa, anaerobic gram-positive, and anaerobic gram-negative bacteria. The first use of this antibiotic was to suppress protozoans such as Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. It has been used to repress the growth of gram-negative anaerobes belonging to the Bacteroides and Fusobacterium, and gram-positive anaerobes such aspeptostreptococcus and Clostridia. The advantages of this antibiotic is that it affects a high percentage of gram-negative bacteria and has greater tissue penetration.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
Metronidazole is a limited spectrum antibiotic that actively deters the growth of protozoa, anaerobic gram-positive, and anaerobic gram-negative bacteria. The first use of this antibiotic was to suppress protozoans such as Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. It has been used to repress the growth of gram-negative anaerobes belonging to the Bacteroides and Fusobacterium, and gram-positive anaerobes such aspeptostreptococcus and Clostridia. The advantages of this antibiotic is that it affects a high percentage of gram-negative bacteria and has greater tissue penetration.
Solubility
Soluble in water (10 mg/ml at 20°C), ethanol, methanol, chloroform, and dimethyl sulfoxide.
Notes
Store at 4°C.
RUO – Research Use Only
General References:
- Paul Rutgeerts.; Martin Hiele.; Karel Geboes.; Marc Peeters.; Freddy Penninckx.; Raymond Aerts.; Raymond Kerremans. Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection. Gastroenterology. 1995, 108 (6),1617-1621.
- DavidG. Teasley.; MaryM. Olson.; RogerL. Gebhard.; DaleN. Gerding.; LanceR. Peterson.; MichaelJ. Schwartz.; JamesT. Lee JR. Prospective Randomised Trial Of Metronidazole Versus Vancomycin For Clostridium-Difficile-Associated Diarrhoea And Colitis.The Lancet. 1983, 322 (8358),1043-1046.